Ajanta Pharma is currently trading at Rs. 1795.35, down by 5.65 points or 0.31% from its previous closing of Rs. 1801.00 on the BSE.
The scrip opened at Rs. 1809.95 and has touched a high and low of Rs. 1813.90 and Rs. 1783.80 respectively. So far 5,043 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2150.00 on 28-Oct-2016 and a 52 week low of Rs. 1203.60 on 17-Feb-2016.
Last one week high and low of the scrip stood at Rs. 1833.90 and Rs. 1710.10 respectively. The current market cap of the company is Rs. 15,799.00 crore.
The promoters holding in the company stood at 73.78%, while Institutions and Non-Institutions held 12.43% and 13.79% respectively.
Ajanta Pharma’s Paithan facility in Aurangabad has been issued one observation from the US health regulator. The Paithan facility was recently inspected by the US Food and Drug Administration (USFDA) and had been issued one procedural related ‘483’. The company is in the process of responding to the same within the stipulated time prescribed by USFDA.
Ajanta Pharma is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. The company is engaged in developing, manufacturing and marketing of quality finished dosages across 30+ countries.
